Materias dentro de su búsqueda.
Materias dentro de su búsqueda.
Indicadores sociales
2
Administración
1
Antropología forense
1
Calidad de vida
1
Capital humano
1
Comportamiento organizacional
1
Comunidades indígenas
1
Condiciones sociales
1
Desarrollo sostenible
1
Educación inclusiva
1
Educación superior
1
Estudiantes con discapacidades
1
Exhumación
1
Filosofía de la tecnología
1
Identificación
1
Liderazgo
1
Minorías
1
Muerte
1
Mujeres
1
Personas desaparecidas
1
Realidad virtual
1
-
2981“…Examples include HEY1-NCOA2 in mesenchymal chondrosarcoma, IDH1/2 mutations in chondrosarcoma and TFCP2 rearrangements in rhabdomyosarcoma. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
2982por Halvari, Anne E. M., Ivarsson, Andreas, Halvari, Hallgeir, Dahl, Kari E., Olafsen, Anja H., Solstad, Bård Erlend, Deci, Edward L., Williams, GeoffreyEnlace del recurso
Publicado 2022
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
2983por Smith, Kris A, Hendricks, Benjamin K, DiDomenico, Joseph D, Conway, Beth N, Smith, Tracy L, Azadi, Amir, Fonkem, Ekokobe“…Results: Sixteen patients who met the inclusion criteria constituted a heterogeneous population of patients with diagnoses including eight World Health Organization (WHO) grade IV gliomas (seven glioblastoma, one gliosarcoma), seven WHO grade III gliomas (three oligodendroglioma, four astrocytoma), and one WHO grade II oligodendroglioma. IDH1 mutation status was present for 12 patients, and MGMT methylation status was present for eight patients. …”
Publicado 2022
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
2984por Takahashi, Mikiko, Tomita, Yusuke, Yamada, Shoko Merrit, Yamazaki, Kazuto, Yokoo, Hideaki, Aso, Tatsuya, Kawamoto, Masashi“…Magnetic resonance imaging showed a tumor expanding from the cerebellum to the pons, which was histologically identified as glioblastoma, grade IV, IDH wild type. After tumor resection, the patient received chemoradiotherapy but showed only a partial response. …”
Publicado 2021
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
2985por Scheiter, Alexander, Hierl, Frederik, Winkel, Ingrid, Keil, Felix, Klier-Richter, Margit, Coulouarn, Cédric, Lüke, Florian, Kandulski, Arne, Evert, Matthias, Dietmaier, Wolfgang, Calvisi, Diego F., Utpatel, Kirsten“…Genomic studies have unveiled several promising targets in this disease, including fibroblast growth factor receptor (FGFR) fusions and isocitrate dehydrogenase (IDH) mutations. To fully harness the potential of genomically informed therapies in CCA, it is necessary to thoroughly characterize the available model organisms, including cell lines. …”
Publicado 2022
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
2986por Simanjuntak, Kevin Ariel Tiopan, Al Fauzi, Asra, Christi, Ayu Yoniko, Budiono, Perthdyatama Syifaq, Susilo, Rahadian Indarto, Haq, Irwan Barlian Immadoel, Suroto, Nur Setiawan, Fauziah, Dyah, Djatisoesanto, Wahjoe“…Immunohistochemistry result confirmed the diagnosis of GBM and IDH1 wild type; coexistent with clear cell RCC. …”
Publicado 2022
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
2987por Vera, Ruth, Ibarrola-de-Andrés, Carolina, Adeva, Jorge, Pérez-Rojas, Judith, García-Alfonso, Pilar, Rodríguez-Gil, Yolanda, Macarulla, Teresa, Serrano-Piñol, Teresa, Mondéjar, Rebeca, Madrigal-Rubiales, Beatriz“…Multiple studies have assessed the ability of certain biomarkers, such as BRCA in pancreatic cancer, IDH1 or FGFR2 in biliary tract cancer and microsatellite instability or NTRK fusions in an agnostic tumour fashion, to predict response to treatment. …”
Publicado 2022
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
2988por Rosa, Paolo, De Falco, Elena, Pacini, Luca, Piazza, Amedeo, Ciracì, Paolo, Ricciardi, Luca, Fiorentino, Francesco, Trungu, Sokol, Miscusi, Massimo, Raco, Antonino, Calogero, Antonella“…The biological heterogeneity of glioblastoma, IDH-wildtype (GBM, CNS WHO grade 4), the most aggressive type of brain cancer, is a critical hallmark, caused by changes in the genomic mutational asset and influencing clinical progression over time. …”
Publicado 2022
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
2989por Kim, Yeong Jin, Lee, Tae-Kyu, Noh, Myung-Giun, Jung, Tae-Young, Kim, In-Young, Jung, Shin, Lee, Kyung-Hwa, Moon, Kyung-Sub“…From 2011 to 2020, 187 isocitrate dehydrongenase (IDH)-wild-type GBM patients were analyzed. The patients were classified based on whether GPC was continuously used for at least 3 or 12 months (mos) after GBM diagnosis. …”
Publicado 2022
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
2990“…DNMT3A and IDH1/2 mutations combinatorically regulate the transcriptome and the epigenome in acute myeloid leukemia; yet the mechanisms of this interplay are unknown. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
2991por Yamagishi, Makoto“…They are characterized by a high frequency of abnormalities related to DNA methylation regulators (DNMT3A, TET2, IDH2, etc.) and histone modifiers (EZH2, HDAC, KMT2D/MLL2, CREBBP, EP300, etc.). …”
Publicado 2022
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
2992por Lu, Shuaifei, Li, Caiyin, Jin, Xiaohui, Zhu, Leilei, Shen, Jiduo, Bai, Ming, Li, Yucheng, Xu, Erping“…In addition, baicalin significantly elevated the ATP content and the expression of genes hexokinase 1 (Hk1), pyruvate dehydrogenase E1 alpha 1 (Pdha-1), isocitrate dehydrogenase (Idh), peroxisome proliferator-activated receptor, gamma, coactivator 1 alpha (Pgc-1α), and sirtuin-1 (Sirt1) in the prefrontal cortex. …”
Publicado 2022
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
2993por Gaggero, Gabriele, Carlin, Luca, Valle, Luca, Gnocchi, Giulia, Bennicelli, Elisa, Fiaschi, Pietro“…On immunohistochemical stains, both cells components tested positive for ATRX, p53, and GFAP; larger ganglion-like cells showed synaptophysin and chromogranin-A expression. IDH1 codon 132 mutation, 1p-19q-codeletion, and MGMT methylation were observed. …”
Publicado 2022
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
2994“…No significant difference in gender ratio and IDH-1 and MGMT methylation status between cystic and non-cystic glioblastoma were reported. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
2995“…Moreover, mutational analysis has documented the presence of IDH1, FGFR2, HER2, PRKACA, PRKACB, BRAF, and KRAS gene aberrations. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
2996por Ni, Lulu, Sun, Ping, Zhang, Sujuan, Qian, Bin, Chen, Xu, Xiong, Mengrui, Li, Bing“…RESULTS: Four subtypes were identified in the TCGA and CGGA RNA-seq datasets simultaneously, one of which was an immunosuppressive subtype rich in immunosuppressive factors with low lymphocyte infiltration and an IDH1 mutation. Three co-expressed gene modules related to the immunosuppressive subtype were identified. …”
Publicado 2023
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
2997“…These neoplasms feature a characteristic and similar, but not identical, mutational landscape with mutations in epigenetic modifiers (TET2, DNMT3A, IDH2), RHOA, and T-cell receptor signaling genes. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
2998por Liu, Yongting, Jiang, Zhaohui, Zhou, Xin, Li, Yin, Liu, Ping, Chen, Yihong, Tan, Jun, Cai, Changjing, Han, Ying, Zeng, Shan, Shen, Hong, Feng, Ziyang“…Results: We constructed a prognostic model that identified the NASH-related gene set (DLAT, IDH3B, and MAP3K4), which was validated in a real-world cohort. …”
Publicado 2023
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
2999por Tedaldi, Gianluca, Guerini, Camilla, Angeli, Davide, Furlan, Daniela, Libera, Laura, Lenti, Marco Vincenzo, Grillo, Federica, Fassan, Matteo, Solcia, Enrico, Sessa, Fausto, Paulli, Marco, Di Sabatino, Antonio, Ulivi, Paola, Vanoli, Alessandro“…Rarely, SB-PCCs showed high microsatellite instability, mutations in IDH1 and ERBB2 genes, or FGFR2 amplification (one case each), which are established or promising therapeutic targets in such aggressive cancers. …”
Publicado 2023
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
3000